In addition, the T2D ASC (NC+C) and Adra2a knocked-down T2D ASC (knockdown+C) groups were treated with 10 μM clonidine for 0 min, 15 min, and 30 min, respectively. The gene discussed is ADRA2A; the disease is type 2 diabetes mellitus.